Lung Cancer | Specialty

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Celecoxib: Effective in Former Smokers as Lung Cancer Chemoprevention

July 6th 2011

A recent study revealed that celecoxib (Celebrex), a COX-2 inhibitor, might be a successful lung cancer chemoprevention in former smokers.

Screening With Low-Dose CT Scan Reduces Deaths From Lung Cancer

June 30th 2011

Patients screened with low-dose helical computed tomography (CT) reduced their risk of dying of lung cancer by 20% compared with chest x-ray.

Dr. Kris Describes the Genetic Mutation Screening Study

June 30th 2011

Dr. Mark Kris from MSKCC Describes the Genetic Mutation Screening Multicenter Study

Dr. West on ALK-NSCLC Crizotinib Survival Benefit

June 30th 2011

Dr. H. Jack West from Swedish Cancer Institute Discusses ALK-NSCLC Crizotinib Survival Benefit

Dr. Kris Discusses Tests Available for Lung Cancer

June 28th 2011

Dr. Kris from Memorial Sloan-Kettering Discusses Tests Available for Lung Cancer

Dr. Kris Discusses the Pemetrexed Trial Results

June 23rd 2011

Dr. Mark Kris from Memorial Sloan-Kettering Cancer Center Discusses the Pemetrexed Clincal Trial Results

Dr. West Discusses Crizotinib in ALK-NSCLC Trial Results

June 23rd 2011

Dr. Jack West from the Swedish Cancer Institute Discusses Crizotinib in ALK-NSCLC Trial Results

PER Gatherings Focus on Breast, Lung Cancers

June 23rd 2011

Internationally known experts will discuss the latest research in breast and lung cancers at 2 conferences that the Physicians' Education Resource (PER) is hosting in California in August.

The Landscape of Chemoprevention in Lung Cancer: A Conversation With Waun K. Hong, MD, PhD

June 22nd 2011

Over the past 25 years, multiple lung cancer chemoprevention trials have missed the mark with agents that looked good on paper but lacked the molecular biology support to make a difference.

FDA Mandates Graphic Cigarette Label Warnings

June 21st 2011

In an effort to draw attention to the dangers of tobacco, the FDA has mandated the inclusion of graphic warnings to cigarette packs and advertisements.

Iloprost Causes Regression of Endobronchial Dysplasia in Former Smokers

June 21st 2011

Results of a phase II trial showed that former smokers had significant regression of endobronchial dysplasia when treated with iloprost.

Dr. Vogelzang on Cabozantinib Clinical Trial Results

June 20th 2011

Dr. Nicholas J. Vogelzang from the Comprehensive Cancer Centers of Nevada on Cabozantinib Clinical Trial Results

Dr. Paz-Ares Discusses the Use of Pemetrexed for NSCLC

June 17th 2011

Dr. Paz-Ares From Seville University Hospital Discusses the Use of Pemetrexed for NSCLC

Menthol Cigarettes Not More Likely to Cause Lung Cancer Than Nonmenthol Cigarettes

June 15th 2011

New results appear to undercut the longstanding notion that individuals who smoke menthol cigarettes have a higher risk of lung cancer than those who smoke nonmenthol cigarettes

Dr. Paz-Ares Discusses Pemetrexed Clinical Trial

June 13th 2011

Dr Paz-Ares from Seville University Hospital Discusses Pemetrexed Clinical Trial

Socioeconomic Status Bears Little Impact on Survival Rates

June 10th 2011

Primary cancers of the lung, esophagus, and pancreas-all of which have a poor prognosis-account for >35% of all cancer deaths in the United States annually

Chemoradiotherapy Before Surgery May Prolong Survival in Locally Advanced Lung Cancer

June 9th 2011

Patients with node-negative, locally advanced lung tumors who undergo induction chemoradiotherapy appear to survive significantly longer than patients who undergo surgical resection without induction chemoradiotherapy

Pemetrexed Maintenance Improves Progression-Free Survival in Patients With NSCLC

June 6th 2011

Continuation maintenance with pemetrexed (Alimta) improves progression-free survival in patients with advanced nonsquamous non–small cell lung cancer

Dr. Kris on the Use of Genetic Testing in Lung Cancer

June 6th 2011

Dr. Kris From Memorial Sloan-Kettering Cancer Center on the Use of Genetic Testing in Lung Cancer

Genetic Testing Delivers Personalized Lung Cancer Therapy

June 5th 2011

Taking a page from breast cancer treatment, clinicians managing lung cancer patients can now detect mutations that drive the development of lung cancer

NEXT PAGE
PREVIOUS PAGE